Clinician's Parkinson's Disease Knowledge Assessment Survey scores before and after the Parkinson's Disease Inpatient Clinical Knowledge and Management Program.
A 20-question survey was administered to PD clinicians for a group measurement of PD knowledge. Scores ranged from 0 - 100% and reflected the percentage of clinicians who correctly answered the question. If 70% or more clinicians correctly answered the question, the group was considered knowledgeable on that topic; if \<70% of clinicians responded incorrectly, they were considered not knowledgeable on the information that the question
Group
Value
95% CI
Clinicians' Knowledge Before Educational Intervention
68.50
0 – 100
Clinicians' Knowledge After Educational Intervention
78.75
0 – 100
Number of PD Medications Administered on Time (15 Minute Window)Secondary· within 15 minutes post PD medication administration time
The number of Parkinson's Disease (PD) medications administered within the 15-minute timeframe at baseline
Group
Value
95% CI
Retrospective Patient Outcomes
678
Number of Patients With Contraindicated Medications Administered.Secondary· 6 months
Measure the number of patients who were adminstered contraindicated medications
Group
Value
95% CI
Retrospective Patient Outcomes
21
Number Patients With Falls, Falls With Injury, Positive CAM/Mini-cogSecondary· 6 Months
The number of falls, number of falls with injury, and number of patients with positive Confusion Assessment Method (CAM)/Mini-Cog scores) in hospitalized patients.
Mini-cog is performed on all admitted patients 65 years and older and is a quick screening for "cognitive vital sign" and early dementia detection. The scale classifies patients as being positive or negative for dementia.
The Confusion Assessment Method (CAM) is performed on all adult admissions at the time of admission with reporting 1) every shift if the first test is positive, or 2) daily if the first test is negative. It impro
Number of falls
Group
Value
95% CI
Retrospective Patient Outcomes
1
Number of falls with injury
Group
Value
95% CI
Retrospective Patient Outcomes
0
Number of patients with positive CAM scores
Group
Value
95% CI
Retrospective Patient Outcomes
47
Number of patients with abnormal mini-cog scores
Group
Value
95% CI
Retrospective Patient Outcomes
45
Length of Stay in Hospitalized Parkinson's Disease Patients.Secondary· 6 months
Average length of stay in hospitalized Parkinson's Disease patients
Group
Value
95% CI
Retrospective Patient Outcomes
6.1
± 6.6
Sponsor's own description
This study will focus on patients with Parkinson's Disease in the adult inpatient units of Hackensack University Medical Center. We are measuring the effect of a Parkinson's Disease Inpatient Clinical Knowledge and Management Program on adherence to Parkinson's Disease medication using a Parkinson's Disease Identification Wrist Band, smartwatch and medication schedule card
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
NCT07399496 — Accelerated TMS for Apathy in PD
· NA
· recruiting
NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
· Phase 1
· recruiting
NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients
· NA
· recruiting
NCT06848205 — Percept Transitions in FOG and PD
· NA
· recruiting
NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P
· Phase 2
· recruiting
NCT06987708 — Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers
· NA
· not yet recruiting
NCT06575894 — Implementing Mental Health Programs Across Communities in Iowa & Indiana for Transformation
· NA
· not yet recruiting
NCT07442669 — Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration
· NA
· not yet recruiting
NCT06991166 — OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hackensack Meridian Health
Last refreshed: 18 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03888287.